scispace - formally typeset
M

Maria B. Lai

Researcher at University of Colorado Boulder

Publications -  8
Citations -  461

Maria B. Lai is an academic researcher from University of Colorado Boulder. The author has contributed to research in topics: Cancer & Frizzled. The author has an hindex of 7, co-authored 7 publications receiving 412 citations. Previous affiliations of Maria B. Lai include Idaho State University.

Papers
More filters
Journal ArticleDOI

Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts.

TL;DR: It is found that TiO2 micro- and nanoparticles induced cell death on both human cell types in a concentration-related manner and it was noted that zinc oxide (ZnO) nanoparticles were the most effective,TiO2 nanoparticles the secondmost effective, and magnesium oxide (MgO), the least effective in inducing cell death in U87 cells.
Journal Article

Glycolytic enzyme inhibitors affect pancreatic cancer survival by modulating its signaling and energetics.

TL;DR: There may be a cross-talk between signaling pathways and glycolysis in regulating Panc-1 cell survival and signaling, and a combination of agents that inhibit both energy production and cell signaling may provide a novel and effective approach to target pancreatic cancer effectively.
Journal ArticleDOI

TSPAN12 Is a Norrin Co-receptor that Amplifies Frizzled4 Ligand Selectivity and Signaling

TL;DR: It is reported that TSPAN12 is an essential component of the NDP receptor complex and interacts with FZD4 and NDP via its extracellular loops, consistent with an action as co-receptor that enhances FzD4 ligand selectivity for NDP.
Journal ArticleDOI

Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A

TL;DR: The results clearly demonstrate a differential regulation of signaling pathways by various isoflavones in OSCC cell lines, and tumor progression models can be utilized to study the preventive and therapeutic roles of isofavones in oral cancer cell lines.
Proceedings ArticleDOI

Abstract 4403: Differential cytotoxic effects of atorvastatin in human hepatocellular carcinoma and pancreatic adenocarcinoma cells

TL;DR: The preliminary findings suggest that statin treatment may be beneficial as a therapeutic avenue for pancreatic cancer but may not have the same benefits for liver cancer.